2015 Review: What Exciting Developments Have Been Made in Neurodegenerative Disease?

24/11/2015 - 9 minutes

Since both Alzheimer’s Disease and Parkinson’s combined affect up to 50 million people worldwide, it is no wonder this new wave of break-through milestones is getting the industry excited…

brain_cnsThe Central Nervous System (CNS) comprises many complex tissues and highly specialized cell types, mutation in which can cause an array of deadly and chronic diseases. Some of these have severe Motor-ability consequences (e.g. Huntington’s, Parkinson’s, Motor Neurone Disease and Multiple Sclerosis), whilst others relay more damage to the cognitive abilities of a sufferer (i.e. Alzheimer’s and Dementia).

After many years of disappointment in the field, this year has proven to yield some major successes in Neurodegenerative disease, which is now experiencing a huge revival in the Biotech industry. Novel ideas and research areas in the CNS have been piling up Alzheimer’s, Parkinson’s and Huntington’s success-stories throughout 2015…

Pursuit of the Holy Grail in Alzheimer’s

Alzheimer’s destroys cognitive function over-time, with confusion and memory-loss leading to intense emotional distress and loss of independence.

This content is available exclusively to our paying members.

Our members receive the following benefits:

  • Unlock premium articles
  • Download our industry reports
  • Remove all banner ads
  • Access 1,500+ archived posts
  • Support our independent media
Already a member? Sign in
Do you want to remove this advert? Become a member!
Do you want to remove this advert? Become a member!

Support Us

Become a Member